⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 9, 2019Lung CancerOpen Access

Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer

Mengdi Cong Hui Feng Jialiang Ren Xu Qian Lining Cong Zhen-zhou Hou Yuan-yuan Wang Gaofeng Shi

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

A radiomics model using the venous phase of CE-CT has potential for predicting LNM in pre-surgical CT-based stage IA NSCLC patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cong et al. (2019) studied this question.

synapsesocial.com/papers/69d6b4ba733a2b54c8aa80b3 https://doi.org/10.1016/j.lungcan.2019.11.003

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1From whole-exome sequencing to functional insight: Characterization of rare germline variants in lung cancerLung Cancer · 2026
2Second-line therapy in extensive-stage small cell lung cancer: an unmet need highlighted by real-world evidence from the LALUCA registryLung Cancer · 2026
3More than a risk factor: alcohol use following diagnosis in non-small cell lung cancer patientsLung Cancer · 2026
4Long-term efficacy and adherence of a lung cancer screening strategy with extended LDCT intervals: Results from the BioMILD trialLung Cancer · 2026
5Outcomes of long-term responders to immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). A retrospective regional studyLung Cancer · 2026

Longitudinal transcriptomic profiling of paired early and metastatic EGFR-mutant lung adenocarcinomas reveals molecular programs associated with disease progressionLung Cancer · 2026
Discordance in pleural mesothelioma response classification and modelling of impact on clinical trialsLung Cancer · 2026
Standard targeted therapy implementation for driver alterations newly identified by comprehensive genomic profiling in clinically driver-negative advanced NSCLCLung Cancer · 2026
Subtyping limited stage small cell lung cancer (LS SCLC) reveals inflammatory subtypes with improved chemoradiotherapy outcomesLung Cancer · 2026
Artificial intelligence–based assessment of tumor bed stroma in non–small cell lung cancer after neoadjuvant therapy: Association with pathologic response and survival. A multicenter studyLung Cancer · 2026

More from Lung Cancer

More from Hebei Medical University

More from Fourth Hospital of Hebei Medical University

More from Hospital of Hebei Province